首页> 外文期刊>CNS neuroscience & therapeutics. >Intracerebroventricular streptozotocin‐induced Alzheimer's disease‐like sleep disorders in rats: Role of the GABAergic system in the parabrachial complex
【24h】

Intracerebroventricular streptozotocin‐induced Alzheimer's disease‐like sleep disorders in rats: Role of the GABAergic system in the parabrachial complex

机译:大鼠脑室内链脲佐菌素诱发的阿尔茨海默氏病样睡眠障碍:GABA能系统在臂旁副复合物中的作用

获取原文
           

摘要

Aim Sleep disorders are common in Alzheimer's disease (AD) and assumed to directly influence cognitive function and disease progression. This study evaluated sleep characteristics in a rat model of AD that was induced by intracerebroventricular streptozotocin (STZ) administration and assessed the possible underlying mechanisms. Methods Cognition ability was assessed in the Morris water maze in rats. Sleep parameters were analyzed by electroencephalographic and electromyographic recordings. Neuronal activity in brain areas that regulate sleep‐wake states was evaluated by double‐staining immunohistochemistry. High‐performance liquid chromatography with electrochemical detection was used to detect neurotransmitter levels. Results Fourteen days after the STZ injection, the rats exhibited sleep disorders that were similar to those in AD patients, reflected by a significant increase in wakefulness and decreases in nonrapid eye movement (NREM) sleep and rapid eye movement (REM) sleep. The c‐Fos expression analysis indicated that neuronal activity and the number of neurons in the dorsal raphe nucleus and locus coeruleus decreased in STZ‐injected rats. In the ventrolateral preoptic nucleus (VLPO), the activity of γ‐aminobutyric acid (GABA) neurons was suppressed. In the arousal‐driving parabrachial nucleus (PBN), GABAergic activity was suppressed, whereas glutamatergic activity was promoted. The neurotransmitter analysis revealed a reduction in GABA in the VLPO and PBN and elevation of glutamate in the PBN. A direct injection of the GABAA receptor antagonist bicuculline in the PBN in normal rats induced a similar pattern of sleep disorder as in STZ‐injected rats. A microinjection of GABA in the PBN improved sleep disorders that were induced by STZ. Conclusion These results suggest that the reduction in GABAergic inhibition in the PBN and VLPO may be involved in sleep disorders that are induced by STZ. Our novel findings encourage further studies that investigate mechanisms of sleep regulation in sporadic AD.
机译:目的睡眠障碍在阿尔茨海默病(AD)中很常见,被认为直接影响认知功能和疾病进展。这项研究评估了由脑室内链脲佐菌素(STZ)诱导的AD大鼠模型的睡眠特征,并评估了可能的潜在机制。方法评估大鼠莫里斯水迷宫中的认知能力。通过脑电图和肌电图记录分析睡眠参数。通过双重染色免疫组织化学评估了调节睡眠-觉醒状态的大脑区域的神经元活动。采用电化学检测的高效液相色谱法检测神经递质水平。结果注射STZ后的第14天,大鼠表现出与AD患者相似的睡眠障碍,这表现为清醒度显着增加,非快速眼动(NREM)睡眠和快速眼动(REM)睡眠减少。 c-Fos表达分析表明,注射STZ的大鼠背缝核和蓝斑中核的神经元活性和神经元数量减少。在腹外侧视前核(VLPO)中,γ-氨基丁酸(GABA)神经元的活性受到抑制。在唤醒驾驶的臂旁核(PBN)中,GABA能活性被抑制,而谷氨酸能活性被促进。神经递质分析显示,VLPO和PBN中的GABA降低,PBN中的谷氨酸升高。在正常大鼠的PBN中直接注射GABAA受体拮抗剂bicuculline可以诱发与STZ注射的大鼠类似的睡眠障碍。在PBN中微量注射GABA可改善STZ诱导的睡眠障碍。结论这些结果表明,PBN和VLPO中GABA能抑制的降低可能与STZ诱发的睡眠障碍有关。我们的新发现鼓励进行进一步研究,以研究散发性AD中的睡眠调节机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号